Immuron (IMRN) Cash from Operations (2016 - 2024)
Immuron (IMRN) posted quarterly Cash from Operations of 2611499.82 for Q4 2024, down 100.19% year-over-year from 1339354581.49 in Q1 2024, and down 100.19% quarter-over-quarter from 1304478.16 in Q4 2023.
Immuron (IMRN) Cash from Operations (2016 - 2024) Analysis & Trends
Immuron's Cash from Operations history runs 9 years deep, the most recent figure standing at 2611499.82 for Q4 2024.
- In Q4 2024, Cash from Operations fell 100.19% year-over-year to 2611499.82; the TTM figure through Dec 2024 stood at 6642520.67 (down 5.68% YoY), while the FY2025 annual figure was 6136949.0, down 4.37% from the prior year.
- Cash from Operations for Q4 2024 stood at 2611499.82, down from 1304478.16 in the prior quarter.
- The five-year high for Cash from Operations was 1479.41 in Q4 2021, with the low at 3140860.1 in Q2 2021.
- The 5-year median for Cash from Operations is 2062823.69 (2020), against an average of 1867643.83.
- The sharpest annual moves came in 2021 and 2022: Cash from Operations soared 100.05% in 2021, then tumbled 67154.97% in 2022.
- Immuron's Cash from Operations stood at 2709405.0 in 2020, then jumped by 100.05% to 1479.41 in 2021, then sank by 67154.97% to 992017.0 in 2022, then tumbled by 31.5% to 1304478.16 in 2023, then plunged by 100.19% to 2611499.82 in 2024.
- Business Quant data shows IMRN's Cash from Operations at 2611499.82 in Q4 2024, 1304478.16 in Q4 2023, and 1734525.69 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 728.46 Mn |
| 10 | Immuron | 6.75 Mn | 6.73 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -2.61 Mn |
| Dec 31, 2024 | -2.61 Mn |
| Dec 31, 2023 | -1.30 Mn |
| Dec 31, 2023 | -1.30 Mn |
| Jun 30, 2023 | -1.73 Mn |
| Jun 30, 2023 | -1.73 Mn |
| Dec 31, 2022 | -992,017.00 |
| Dec 31, 2022 | -992,017.00 |
| Jun 30, 2022 | -2.25 Mn |
| Jun 30, 2022 | -2.25 Mn |
| Dec 31, 2021 | 1,479.41 |
| Dec 31, 2021 | 1,479.41 |
| Jun 30, 2021 | -3.14 Mn |
| Jun 30, 2021 | -3.14 Mn |
| Dec 31, 2020 | -2.71 Mn |
| Dec 31, 2020 | -2.71 Mn |
| Jun 30, 2020 | -2.06 Mn |
| Jun 30, 2020 | -2.06 Mn |
| Dec 31, 2019 | -1.56 Mn |
| Dec 31, 2019 | -1.56 Mn |